Attached files

file filename
8-K - FORM 8K - Cinedigm Corp.form8k_1535958.htm
EX-23.1 - CONSENT OF EISNERAMPER LLP - Cinedigm Corp.exh23-1_1536482.htm
EX-99.2 - ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY - Cinedigm Corp.exh99-2_1536598.htm
Exhibit 99.1
ITEM 6.  SELECTED FINANCIAL DATA

The following tables set forth our selected financial and operating data for the periods indicated, which have been adjusted from previously reported amounts to reflect the reclassification of operations discontinued during the fiscal year ended March 31, 2012 as discussed in note 1 to the Consolidated Financial Statements (refer to Item 8). The selected unaudited financial and operating data should be read together with the other information contained in this document and the audited historical financial statements and the notes thereto included elsewhere in this document.  The historical results here are not necessarily indicative of future results.
 
 
As Adjusted (See note 1 to the Consolidated Financial Statements)
 
For the Fiscal Years Ended March 31,
Statement of Operations Data
(In thousands, except for share and per share data)
Related to Continuing Operations:
2011
 
2010
 
2009
 
2008
 
2007
Revenues
$
58,439
   
$
50,464
   
$
52,096
   
$
47,429
   
$
18,415
 
Direct operating (exclusive of depreciation
  and amortization shown below)
4,329
   
5,004
   
5,960
   
4,958
   
3,518
 
Gross margin
54,110
   
45,460
   
46,136
   
42,471
   
14,897
 
Selling, general and administrative
11,777
   
9,942
   
10,589
   
12,009
   
12,931
 
Provision for doubtful accounts
144
   
(95
)
 
(110
)
 
291
   
265
 
Research and development
256
   
130
   
152
   
146
   
362
 
Restructuring and transition expenses
1,403
   
   
   
   
 
Depreciation and amortization of property
  and equipment
31,916
   
29,834
   
28,934
   
24,479
   
9,545
 
Amortization of intangible assets
333
   
348
   
612
   
1,317
   
658
 
Income (loss) from operations
8,281
   
5,301
   
5,959
   
4,229
   
(8,864
)
                   
Interest income
154
   
312
   
367
   
1,401
   
1,411
 
Interest expense – cash portion
(24,581
)
 
(30,649
)
 
(21,693
)
 
(20,959
)
 
(5,842
)
Interest expense – non-cash, includes
  accretion of note payable discount
(2,410
)
 
(2,934
)
 
(4,745
)
 
(6,995
)
 
(1,811
)
Debt refinancing expense
   
   
   
(1,122
)
 
 
Extinguishment of debt
(4,448
)
 
10,744
   
   
   
 
Other expense, net
(433
)
 
(570
)
 
(366
)
 
(2,187
)
 
(285
)
Change in fair value of warrant liability
3,142
   
2,994
   
   
   
 
Change in fair value of interest rate swap
(1,326
)
 
(8,463
)
 
(4,529
)
 
   
 
Net loss from continuing operations
$
(21,621
)
 
$
(23,265
)
 
$
(25,007
)
 
$
(25,633
)
 
$
(15,391
)
Loss from discontinued operations
(8,237
)
 
(6,243
)
 
(12,197
)
 
(10,054
)
 
(10,608
)
Gain (loss) on sale of discontinued operations
622
   
   
(164
)
 
   
 
Loss from discontinued operations
(7,615
)
 
(6,243
)
 
(12,361
)
 
(10,054
)
 
(10,608
)
Net loss
$
(29,236
)
 
$
(29,508
)
 
$
(37,368
)
 
$
(35,687
)
 
       (25,999
)
Preferred stock dividends
(394
)
 
(400
)
 
(50
)
 
   
 
Net loss attributable to common
  shareholders
$
(29,630
)
 
$
(29,908
)
 
$
(37,418
)
 
$
(35,687
)
 
$
(25,999
)
Basic and diluted net loss per share from
  continuing operations
$
(0.71
)
 
$
(0.82
)
 
$
(0.91
)
 
$
(1.01
)
 
$
(0.65
)
Shares used in computing basic and
  diluted net loss per share (1)
30,794,102
   
28,624,154
   
27,476,420
   
25,576,787
   
23,729,763
 
 
(1)  
For all periods presented, the Company has incurred net losses and, therefore, the impact of dilutive potential common stock equivalents and convertible notes are anti-dilutive and are not included in the weighted shares.

 
1

 


 
As Adjusted (See note 1 to the Consolidated Financial Statements)
 
For the Fiscal Years Ended March 31,
 
(In thousands)
Balance Sheet Data (At Period End):
2011
 
2010
 
2009
 
2008
 
2007
Cash and cash equivalents, restricted available-for-
  sale investments and restricted cash
$
22,979
   
$
24,193
   
$
26,584
   
$
29,910
   
$
29,555
 
Working capital
$
13,713
   
$
15,589
   
$
24,400
   
$
43,347
   
$
45,113
 
Total assets
$
307,488
   
$
297,147
   
$
322,397
   
$
377,677
   
$
301,727
 
Notes payable, non-recourse
$
192,554
   
$
173,301
   
$
195,448
   
$
210,879
   
$
157,510
 
Total stockholders' equity
$
1,787
   
$
11,292
   
$
38,787
   
$
68,007
   
$
90,805
 
Other Financial Data (At Period End):
                 
Net cash provided by (used in) operating activities
$
30,075
   
$
9,948
   
$
33,818
   
$
(443
)
 
$
(19,190
)
Net cash used in investing activities
$
(41,067
)
 
$
(19,394
)
 
$
(34,236
)
 
$
(96,855
)
 
$
(135,277
)
Net cash provided by (used in) financing activities
$
12,646
   
$
2,712
   
$
(13,409
)
 
$
97,577
   
$
147,202
 

 
 
2